The two are different molecules, act on different receptors, were developed toward different goals, and sit on opposite ends of the evidence and regulatory spectrum
Genes & Development, 29 (10), 989999
(Hims & Hers has not faced any federal investigations for its prescribing practices.) Last year, Hims & Hers ran a Super Bowl ad similarly focused on democratizing carespecifically GLP-1s for weight loss
Colonbroom ingredients are very natural and impact the user very positively
Myocardial infarction and stroke are responsible for 75% of all death in patients with diabetes, who present a 2-4 increased incidence of death from coronary artery disease
Clinical trials consistently show tirzepatide produces about 5% more body weight loss than semaglutide, likely due to this dual mechanism